Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan.

Saito, Jumpei; Yoshikawa, Nozomi; Hanawa, Takehisa; Ozawa, Ayuna; Matsumoto, Takahiro; Harada, Tsutomu; Iwahashi, Kana; Nakamura, Hidefumi; Yamatani, Akimasa

Saito, Jumpei; Yoshikawa, Nozomi; Hanawa, Takehisa; Ozawa, Ayuna; Matsumoto, Takahiro; Harada, Tsutomu; Iwahashi, Kana; Nakamura, Hidefumi; Yamatani, Akimasa.

Afiliação

Saito J; Department of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
Yoshikawa N; Division of Clinical Pharmacology and Oral Formulation Development, National Center for Child Health and Development, Tokyo 157-0054, Japan.
Hanawa T; Department of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
Ozawa A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan.
Matsumoto T; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan.
Harada T; R&D Center, Ohara Pharmaceutical Co., Ltd., Koka-shi 520-3403, Japan.
Iwahashi K; Division of Pharmaceutics, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.
Nakamura H; Department of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
Yamatani A; Division of Clinical Pharmacology and Oral Formulation Development, National Center for Child Health and Development, Tokyo 157-0054, Japan.

Pharmaceutics ; 13(8)2021 Aug 17.

Article em En | MEDLINE | ID: mdl-34452228

Palavras-chave

hydrocortisone; oral powder; pediatric formulation; quality assurance; stability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google